MX2009008093A - Procedimientos para la preparacion de compuestos de urea sustituidos con piperidinilo. - Google Patents

Procedimientos para la preparacion de compuestos de urea sustituidos con piperidinilo.

Info

Publication number
MX2009008093A
MX2009008093A MX2009008093A MX2009008093A MX2009008093A MX 2009008093 A MX2009008093 A MX 2009008093A MX 2009008093 A MX2009008093 A MX 2009008093A MX 2009008093 A MX2009008093 A MX 2009008093A MX 2009008093 A MX2009008093 A MX 2009008093A
Authority
MX
Mexico
Prior art keywords
piperidinyl
processes
preparation
urea compounds
substituted urea
Prior art date
Application number
MX2009008093A
Other languages
English (en)
Inventor
Richard D Gless Jr
Original Assignee
Arete Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arete Therapeutics Inc filed Critical Arete Therapeutics Inc
Publication of MX2009008093A publication Critical patent/MX2009008093A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describen procedimientos para la síntesis de compuestos de urea sustituidos con piperidinilo. Esta invención también se refiere a intermediarios novedosos preparados durante esta síntesis.
MX2009008093A 2007-01-29 2008-01-28 Procedimientos para la preparacion de compuestos de urea sustituidos con piperidinilo. MX2009008093A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88711407P 2007-01-29 2007-01-29
US97217707P 2007-09-13 2007-09-13
PCT/US2008/052196 WO2008094862A1 (en) 2007-01-29 2008-01-28 Processes for the preparation of piperidinyl-substituted urea compounds

Publications (1)

Publication Number Publication Date
MX2009008093A true MX2009008093A (es) 2009-08-12

Family

ID=39493517

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008093A MX2009008093A (es) 2007-01-29 2008-01-28 Procedimientos para la preparacion de compuestos de urea sustituidos con piperidinilo.

Country Status (15)

Country Link
US (1) US20080207908A1 (es)
EP (1) EP2125729A1 (es)
JP (1) JP2010516785A (es)
KR (1) KR20090107045A (es)
CN (1) CN101663273A (es)
AR (1) AR065079A1 (es)
AU (1) AU2008210723A1 (es)
BR (1) BRPI0807125A2 (es)
CA (1) CA2675448A1 (es)
EA (1) EA200901063A1 (es)
EC (1) ECSP099599A (es)
IL (1) IL199654A0 (es)
MX (1) MX2009008093A (es)
TW (1) TW200838851A (es)
WO (1) WO2008094862A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090197916A1 (en) * 2007-01-29 2009-08-06 Arete Therapeutics, Inc Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
US7081454B2 (en) * 2001-03-28 2006-07-25 Bristol-Myers Squibb Co. Tyrosine kinase inhibitors
JP4648317B2 (ja) * 2003-08-01 2011-03-09 中外製薬株式会社 マロニル−ＣｏＡデカルボキシラーゼ阻害剤として有用なピペリジン化合物
TW200808723A (en) * 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase

Also Published As

Publication number Publication date
KR20090107045A (ko) 2009-10-12
EA200901063A1 (ru) 2009-12-30
CA2675448A1 (en) 2008-08-07
EP2125729A1 (en) 2009-12-02
US20080207908A1 (en) 2008-08-28
ECSP099599A (es) 2009-09-29
WO2008094862A1 (en) 2008-08-07
BRPI0807125A2 (pt) 2014-04-08
AR065079A1 (es) 2009-05-13
IL199654A0 (en) 2010-04-15
JP2010516785A (ja) 2010-05-20
TW200838851A (en) 2008-10-01
CN101663273A (zh) 2010-03-03
AU2008210723A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
MY148253A (en) Azaadamantane derivatives and methods of use
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MX2010005530A (es) Activadores de receptor de vitamina d nuevos y metodos de elaboracion de los mismos.
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
WO2008127646A3 (en) Transaminase-based processes for preparation of pregabalin
WO2008151170A3 (en) Process for the synthesis of ramelteon and its intermediates
CL2011000936A1 (es) Proceso de preparacion de compuestos derivados de l-alanina protegidos, utiles como intermediarios de la sintesis de compuestos moduladores opioides mu/delta.
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
WO2009005647A3 (en) Compounds and process to prepare chiral intermediates for synthesis of paroxetine
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
TW200740729A (en) Methods for preparing glutamic acid derivatives
ZA201006669B (en) Process for the preparation of synthesis gas,ii
WO2009116081A3 (en) An improved process for the preparation of aprepitant
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
TWI374886B (en) Processes for preparing intermediates of pemetrexed
WO2012015687A3 (en) Drug-ligand conjugates, synthesis thereof, and intermediates thereto
IN2012DN02000A (es)
MX2010003056A (es) Polimorfos de valomaciclovir.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal